Research ArticleOriginal Research

Outcomes From Treatment of Infertility With Natural Procreative Technology in an Irish General Practice

Joseph B. Stanford, Tracey A. Parnell and Phil C. Boyle
The Journal of the American Board of Family Medicine September 2008, 21 (5) 375-384; DOI: https://doi.org/10.3122/jabfm.2008.05.070239

References

  1. ↵
    National Collaborating Centre for Women's and Children's Health (United Kingdom). Fertility: assessment and treatment for people with fertility problems. In: National Institute for Clinical Excellence. London: Royal College of Obstetricians and Gynaecologists Press; 2004.
  2. ↵
    Hull MG. Infertility treatment: relative effectiveness of conventional and assisted conception methods. Hum Reprod 1992; 7: 785–96.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Copperman AB, DeCherney AH. Turn, turn, turn. Fertil Steril 2006; 85: 12–3.
    OpenUrlPubMed
  4. ↵
    Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 1998; 77: 239–43.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102: 767–72.
    OpenUrlPubMedWeb of Science
  6. ↵
    Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346: 731–7.
    OpenUrlCrossRefPubMedWeb of Science
  7. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346: 725–30.
    OpenUrlCrossRefPubMedWeb of Science
  8. Stromberg B, Dahlquist G, Ericson A, Finnstrom O, Koster M, Stjernqvist K. Neurological sequelae in children born after in-vitro fertilisation: a population-based study. Lancet 2002; 359: 461–5.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Mitchell AA. Infertility treatment–more risks and challenges. N Engl J Med 2002; 346: 769–70.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Multiple gestation pregnancy. The ESHRE Capri Workshop Group. Hum Reprod 2000; 15: 1856–64.
    OpenUrlAbstract/FREE Full Text
  11. Schieve LA, Peterson HB, Meikle SF, et al. Live-birth rates and multiple-birth risk using in vitro fertilization. JAMA 1999; 282: 1832–8.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Kissin DM, Schieve LA, Reynolds MA. Multiple-birth risk associated with IVF and extended embryo culture: USA, 2001. Hum Reprod 2005; 20: 2215–23.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Boyle PC. NaPro technology and infertility: a family physician's approach. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 653–66.
  14. ↵
    Hilgers TW. What is NaProTechnology? In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 19–28.
  15. ↵
    Hilgers TW, Daly KD, Hilgers SK, Prebil AM. Creighton Model Fertility Care System: a standardized, case management appproach to teaching, book 1, 2nd ed. Omaha (NE): Pope Paul VI Institute Press; 2002.
  16. ↵
    Hilgers TW. Introduction to the Creighton Model System. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 43–56.
  17. ↵
    Hilgers TW. Medical treatment of ovarian and target organ dysfunction. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 607–34.
  18. ↵
    Hilgers TW. Summary of NaPro technology biomarkers. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 1137–62.
  19. ↵
    Hilgers TW. NaPro technology in infertility: evaluation and treatment. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 509–40.
  20. ↵
    The Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene in women. Fertil Steril 2003 80: 1302–8.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Check JH, Adelson HG, Wu CH. Improvement of cervical factor with guaifenesin. Fertil Steril 1982; 37: 707–8.
    OpenUrlPubMedWeb of Science
  22. ↵
    Check JH. Diagnosis and treatment of cervical mucus abnormalities. Clin Exp Obstet Gynecol 2006; 33: 140–2.
    OpenUrlPubMed
  23. ↵
    Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002; 17: 2287–99.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Stanford JB, Smith KR, Dunson DB. Vulvar mucus observations and the probability of pregnancy. Obstet Gynecol 2003; 101: 1285–93.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Hilgers TW. Using progesterone support during pregnancy. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 725–46.
  26. Hilgers TW. Assessing progesterone during pregnancy. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 713–24.
  27. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–85.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–24.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Hilgers TW. Effectiveness of NaPro technology in the treatment of infertility. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 677–94.
  30. ↵
    Hilgers T. The Creighton Model FertilityCare System: an introductory booklet for new users, 5th ed. Omaha (NE): Pope Paul VI Institute Press; 2001.
  31. ↵
    Hilgers TW. Targeted hormone assessment of the menstrual cycle. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 251–8.
  32. ↵
    Danis P. A family physician's experience with NaPro technology. In: Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004: 1101–14.
  33. ↵
    Daya S. Pitfalls in the design and analysis of efficacy trials in subfertility. Hum Reprod 2003; 18: 1005–9.
    OpenUrlFREE Full Text
  34. ↵
    Vail A, Gardener L. Reply to Dickey: clinical as well as statistical knowledge. Hum Reprod 2003; 18: 2495–8.
    OpenUrlFREE Full Text
  35. ↵
    Lintsen AM, Eijkemans MJ, Hunault CC, et al. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod 2007; 22: 2455–62.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Thurin A, Hausken J, Hillensjo T, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med 2004; 351: 2392–402.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    Centers for Disease Control and Prevention. Assisted reproductive technology success rates 2003. National summary and fertility clinic reports. Washington, DC: US Department of Health and Human Services; 2003.
  38. ↵
    Stolwijk AM, Hamilton CJ, Hollanders JM, Bastiaans LA, Zielhuis GA. A more realistic approach to the cumulative pregnancy rate after in-vitro fertilization. Hum Reprod 1996; 11: 660–3.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Stolwijk AM, Wetzels AM, Braat DD. Cumulative probability of achieving an ongoing pregnancy after in-vitro fertilization and intracytoplasmic sperm injection according to a woman's age, subfertility diagnosis and primary or secondary subfertility. Hum Reprod 2000; 15: 203–9.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod 1997; 12: 1582–8.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril 1995; 64: 22–8.
    OpenUrlPubMedWeb of Science
  42. Eimers JM, te Velde ER, Gerritse R, Vogelzang ET, Looman CW, Habbema JD. The prediction of the chance to conceive in subfertile couples. Fertil Steril 1994; 61: 44–52.
    OpenUrlPubMedWeb of Science
  43. Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol 2004; 103: 51–6.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693–7.
    OpenUrlCrossRefPubMed
  45. ↵
    Juul S, Karmaus W, Olsen J. Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark. France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod 1999; 14: 1250–4.
    OpenUrl
  46. ↵
    Land JA, Evers JL. What is the most relevant standard of success in assisted reproduction? Defining outcome in ART: a Gordian knot of safety, efficacy and quality. Hum Reprod 2004; 19: 1046–8.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Human Fertilisation and Embryology Authority. Ninth annual report and accounts. London: Human Fertilisation and Embryology Authority; 2000.
  48. ↵
    Wright VC, Schieve LA, Reynolds MA, Jeng G. Assisted reproductive technology surveillance–United States, 2000. MMWR Surveill Summ 2003; 52: 1–16.
    OpenUrlPubMed
  49. ↵
    Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod 2001; 16: 259–62.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Tan SL, Doyle P, Maconochie N, et al. Pregnancy and birth rates of live infants after in vitro fertilization in women with an without previous in vitro fertilization pregnancies: a study of eight thousand cycles at one center. Am J Obstet Gynecol 1994; 170(1 Pt 1): 34–40.
    OpenUrlPubMedWeb of Science
  51. ↵
    Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000; 355: 13–8.
    OpenUrlCrossRefPubMedWeb of Science
  52. ↵
    Johnson NP, Proctor M, Farquhar CM. Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database. Hum Reprod 2003; 18: 947–54.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Pandian Z, Bhattacharya S, Vale L, Templeton A. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev 2005; (2): CD003357.
  54. ↵
    Olivennes F, Fanchin R, Ledee N, Righini C, Kadoch IJ, Frydman R. Perinatal outcome and developmental studies on children born after IVF. Hum Reprod Update 2002; 8: 117–28.
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Wright VC, Chang J, Jeng G, Chen M, Macaluso M. Assisted reproductive technology surveillance–United States, 2004. MMWR Surveill Summ 2007; 56: 1–22.
    OpenUrlPubMed
  56. ↵
    Andersen AN, Goossens V, Ferraretti AP, et al. Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 2008; 23: 756–71.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section